Medfinder
Back to blog

Updated: January 19, 2026

Cataflam Shortage: What Providers and Prescribers Need to Know in 2026

Author

Peter Daggett

Peter Daggett

Healthcare provider reviewing Cataflam shortage information

A clinical guide for prescribers on Cataflam (diclofenac potassium) availability in 2026, including substitution guidance and patient management strategies.

Patients presenting with unfilled Cataflam prescriptions are a persistent challenge in many practice settings. This guide provides a concise clinical overview of the Cataflam availability situation in 2026, practical substitution guidance, and strategies for minimizing disruption to patient care.

Current Availability Status (2026)

The branded Cataflam (diclofenac potassium, Novartis) is no longer manufactured in the United States. Generic diclofenac potassium 50 mg tablets are available through multiple generic manufacturers (Teva, Mylan/Viatris) with no active FDA or ASHP shortage listing as of 2026. The practical issue is pharmacy-level stocking inconsistency, not a supply chain failure.

Key distinction: Prescriptions written as "Cataflam" may be flagged as discontinued in pharmacy dispensing systems, even when the generic equivalent is available. A DAW-0 (substitution permitted) notation and writing the prescription as "diclofenac potassium 50 mg tablets" will minimize dispensing delays.

Clinical Profile: Diclofenac Potassium vs. Diclofenac Sodium

Understanding the pharmacokinetic differences between diclofenac potassium and diclofenac sodium is critical for substitution decisions:

Diclofenac potassium (Cataflam): Immediate-release; onset 30-60 min; T-max approximately 1 hour; suitable for acute pain and primary dysmenorrhea

Diclofenac sodium enteric-coated (Voltaren): Delayed-release; onset 1-2 hours; T-max 2-3 hours; more appropriate for chronic inflammatory conditions requiring sustained coverage

These formulations are NOT bioequivalent and are not automatically interchangeable. For patients requiring rapid onset (e.g., menstrual pain, acute musculoskeletal injury), substituting to a delayed-release formulation may result in inadequate early pain control.

Substitution Options by Indication

For Primary Dysmenorrhea:

Ibuprofen 400-800 mg q4-6h (first-line OTC; FDA-approved for dysmenorrhea)

Naproxen sodium 500 mg q8-12h (available Rx; longer duration)

Mefenamic acid 500 mg loading, then 250 mg q6h (FDA-approved for dysmenorrhea; Rx only)

For Osteoarthritis / Rheumatoid Arthritis:

Meloxicam 7.5-15 mg QD (widely stocked, COX-2 preferential, often on $4 generic programs)

Diclofenac sodium DR 50-75 mg BID-TID (if onset latency is acceptable)

Naproxen 250-500 mg BID (Rx); or naproxen sodium 220 mg OTC, up to 660 mg/day

Celecoxib 100-200 mg QD-BID (best option for GI-sensitive patients; prior auth may apply)

For Acute Musculoskeletal Pain:

Ibuprofen 400-800 mg q6-8h (first-line; widely available OTC and Rx)

Ketorolac (Toradol) IM/IV for short-term use in acute settings

Prescribing Adjustments That Help Patients

To minimize dispensing friction for patients who still need diclofenac potassium:

Write prescriptions as "diclofenac potassium 50 mg tablets" rather than "Cataflam"

Add a note on the prescription: "Generic diclofenac potassium 50 mg acceptable"

Direct patients to pharmacies most likely to stock it: larger chains (CVS, Walgreens, Walmart) or mail-order pharmacies

Consider 90-day supplies when covered by insurance to reduce frequency of dispensing challenges

Supporting Patients in Finding Their Medication

For practices looking to streamline patient support, medfinder for providers enables you to send patients a direct link to find their medication at local pharmacies. medfinder calls pharmacies on the patient's behalf and texts them results — reducing callbacks to your office about unfilled prescriptions.

Patient Communication Talking Points

When counseling patients who are having trouble filling Cataflam:

"The brand Cataflam is no longer made, but the generic — diclofenac potassium 50 mg — is available. Ask the pharmacist specifically for the generic."

"If your pharmacy doesn't have it, call around or use medfinder.com to have pharmacies checked for you."

"If you can't find it, call the office and we can discuss an alternative."

For a complete provider workflow guide, see How to Help Your Patients Find Cataflam in Stock.

Frequently Asked Questions

Yes. Cataflam was the brand name for diclofenac potassium 50 mg immediate-release tablets. The brand has been discontinued in the U.S. by Novartis, but the generic diclofenac potassium 50 mg is available from multiple manufacturers and is clinically equivalent.

Not automatically. Diclofenac potassium (Cataflam) is immediate-release with a 30-60 minute onset, while most diclofenac sodium formulations are delayed-release with a 1-2 hour onset. For acute pain or dysmenorrhea, the difference in onset can be clinically meaningful. Always assess whether the indication requires rapid onset before substituting.

Write prescriptions as 'diclofenac potassium 50 mg tablets' rather than 'Cataflam' to avoid pharmacy dispensing system flags. Allow generic substitution (DAW-0) and direct patients to larger chain pharmacies which are more likely to stock the generic consistently.

No. As of 2026, there is no active FDA or ASHP-listed shortage for diclofenac potassium tablets. The availability challenges stem from brand discontinuation and inconsistent pharmacy stocking, not a manufacturing or supply chain shortage.

For arthritis: meloxicam (once daily, widely stocked), diclofenac sodium DR, or celecoxib for GI-sensitive patients. For dysmenorrhea: ibuprofen 400-800 mg q4-6h or naproxen sodium 500 mg q8-12h. For acute pain: ibuprofen or, in appropriate settings, ketorolac.

Medfinder Editorial Standards

Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.

Read our editorial standards

Patients searching for Cataflam also looked for:

Ibuprofen (Advil, Motrin)Naproxen (Aleve, Naprosyn)Meloxicam (Mobic)Celecoxib (Celebrex)

35,524 have already found their meds with Medfinder.

Start your search today.

35K+
5-star ratingTrusted by 35,524 Happy Patients
      What med are you looking for?
⊙  Find Your Meds
99% success rate
Fast turnaround time
Never call another pharmacy

Need this medication?